Evidence map›Paper›PMID 37063077›Full record

ArticleCNS neuroscience & therapeutics2023

Upregulation of the ZNF148/PTX3 axis promotes malignant transformation of dendritic cells in glioma stem-like cells microenvironment.

Shan Cheng, Liang Liu, Delin Wang, Yongdong Li, Suwen Li, Jiaqi Yuan, Shilu Huang, Zhipeng Xu, Bin Jia, Zhe Li and 1 more

Open access · goldAbstract read
In one paragraph

Article in CNS neuroscience & therapeutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. Hsa_circRNA_0101125 Promotes Proliferation, Migration, and Invasion of Esophageal Squamous Cell Carcinoma via miR-143-3p/ZNF148 Axis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Shan ChengDepartment of Neurosurgery, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.ORCID 0000-0002-7372-9949
Liang LiuDepartment of Neurosurgery, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
Delin WangDepartment of Neurosurgery, Jiande First People's Hospital, Hangzhou, Zhejiang, China.
Yongdong LiDepartment of Neurosurgery, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
Suwen LiDepartment of Neurosurgery, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
Jiaqi YuanDepartment of Neurosurgery, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
Shilu HuangDepartment of Neurosurgery, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
Zhipeng XuDepartment of Neurosurgery, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
Bin JiaState Key Laboratory of Analytical Chemistry for Life Science, Nanjing University, Nanjing, Jiangsu, China.
Zhe LiState Key Laboratory of Analytical Chemistry for Life Science, Nanjing University, Nanjing, Jiangsu, China.
Jun DongDepartment of Neurosurgery, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.ORCID 0000-0002-0026-6680
Soochow University · CNNanjing University · CNHangzhou First People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe recent development of dendritic cell (DC)-based immunotherapy has resulted in advances in glioblastoma multiforme (GBM) treatment. However, the cell fate of DCs in the GBM microenvironment, especially in microenvironments in which glioma stem cell (GSCs)-mediated remodeling has resulted in highly immunosuppressive conditions, has not yet been fully investigated.

methodsObserved the interaction between GSCs and primary cultured DCs in a dual-color tracing model, monoclonal and continuously passaged highly proliferative DCs, and named transformed DCs (t-DCs). The expression of DC-specific surface markers was analyzed using RT-PCR, chromosome karyotype, and flow cytometry. The expression of long pentraxin 3 (PTX3) and its transcription factor zinc finger protein 148 (ZNF148) in t-DCs was detected using qRT-PCR and western blot. CCK8 and transwell assays were conducted to assess the effect of ZNF148 and PTX3 on the proliferation, migration, and invasion of t-DCs. Bioinformatics analysis, dual-luciferase reporter assay, and chromatin immunoprecipitation (ChIP)-qPCR assay were used to explore the relation between ZNF148 and PTX3.

resultsTransformed DCs (t-DCs) still expressed DC-specific surface markers, namely, CD80 and CD11c, and immune-related costimulatory molecules, namely, CD80, CD86, CD40, and ICAM-1. However, the expression levels of these molecules in t-DCs decreased moderately compared to those in naive DCs. Stable overexpression of PTX3 further promoted the proliferation and migration of t-DCs in vitro, decreased the expression of costimulatory molecules, and increased the tumorigenicity of t-DCs in vivo. The transcription factor zinc finger protein 148 (ZNF148) was directly bound to the PTX3 promoter region and enhanced PTX3 expression. Downregulation of ZNF148 significantly decreased PTX3 expression and reduced the proliferation and migration of t-DCs. Overexpression of ZNF148 significantly increased PTX3 expression and promoted the proliferation and migration of t-DCs, achieving the same biological effects as PTX3 overexpression in t-DCs. Simultaneously, the downregulation of ZNF148 partially reversed the effect of PTX3 overexpression in t-DCs.

conclusionThe ZNF148/PTX3 axis played an important role in regulating the malignant transformation of DCs after cross-talk with GSCs, and this axis may serve as a new target for sensitizing GBM to DC-based immunotherapy.

Indexed as

GliomaTranscription FactorsDendritic CellsDNA-Binding ProteinsHumansPentraxinsTumor MicroenvironmentUp-RegulationDNA-Binding ProteinsPentraxinsTranscription FactorsZNF148 protein, humandendritic cellsGBM microenvironmentglioma stem cellsmalignant transformationtranscription factor ZNF148

Identifiers

PMID37063077
PMCPMC10401131
OpenAlexW4366083640

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.